A survey of the variability of DNA banks worldwide

Populations and Genetics: Legal and Socio-Ethical Perspectives

Volumn , Issue , 2003, Pages 123-140

  Palmour, Nicole ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70449362387     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (17)

1. Hembree A. ID, Registration and DNA, Please. Wired News Feb. 26, 2001. Available at: http://www.wired.com/news. Accessed: July 20, 2002.
2. McEwen JK, Reilly PR. A Survey of DNA Diagnostic Laboratories Regarding DNA Banking. Am. J. Hum. Genet. 1995; 56:1477-1486.
3. st International DNA Users Conference. Nov 24-26, 1999. Available at: http://www.interpol.com. Accessed: July 23, 2002.
4. Mandi KD, Feit S, Larson C, Kohane IS. Newborn screening program practices in the United States: Notification, research, and consent. Pediatrics 2002; 2:269-273.
5. European Society of Human Genetics. Population Genetic Screening Programmes: Recommendations of the European Society of Human Genetics, Europe, 2000.
6. World Health Organisation. Proposed International Guidelines on Ethical Issues in Medical Genetics and Genetic Services, Geneva, 1997.
7. Therrell BL, et al. Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: Statement of the Council of Regional networks for genetic services. Biochem. Mol. Med. 1996; 57:116-124.
8. Andrews LB. A conceptual framework for genetic policy: Comparing the medical, public health and fundamental rights models. Washington University Law Quarterly 2001;79:221-285. ~
9. Knoppers BM, Avard D, Cardinal G, Glass KC. Children and incompetent adults in genetic research: consent and safeguards. Nat. Rev. Genet. 2002; 3:221-224.
10. Atkins K, Zuckerman B, Sharfstein JM, Levin D, Blatt RM, Koh HK. A public Response to Emerging Technology: Expansion of the Massachusetts Newborn Screening Program. Public Health Reports 2001; 116:122-131.
11. Levin DE. Public Health Considerations in Newborn Screening. Oral presentation, American Society of Law, Medicine and Ethics; Boston, MA; Sept 20, 2002.
12. Prence EM. A Practical guide for the validation of genetic tests. Genet. Test. 1999; 3:201-205.
13. Center for Disease Control. General Recommendations for Quality Assurance Programs for Laboratory Molecular Genetic Tests. Available at: http://www.phppo.cdc.gov/DLS/genetic/default.asp. Accessed: February 16, 2002.
14. Association for Molecular Pathology Statement. Recommendations for the In-House Development and Operation for Molecular diagnostic Tests. Am. J. of Clin. Path. 1999; 111:449-463.
15. Dequcker E, Ramseden S, Grody WW, Stensel TT, Barton DE. Quality control in molecular genetic testing. Nat. Rev. Genet. 2001; 2:717-723.
16. McGovern MM, Benach MO, Wallebstein S. Desnick, RJ, Keenlyside R. Quality assurance in molecular genetic testing laboratories. JAMA 1999; 218:83 5-840.
17. Robinson RA. Are we failing in molecular genetic testing? Am. J. Clin. Path. 1999; 112:11-13.